Capitalizing Life Science Innovations

        
  GENELUX

Thomas Zindrick, CEO

Genelux (NASDAQ: GNLX)

“Allele, with their high-touch approach and deep understanding of our organization, really helped develop a bespoke approach for us so that they could tell our unique story in a very understandable way to multiple audiences.”​